Table 128Comparison 4 results

TreatmentTotal costsTotal QALYsInc. costsInc. QALYsICER
Nebulised tobramycin£245,83011.35---
Nebulised aztreonam lysine£265,15111.91£19,3210.56£34,348
Combinationa£340,26511.53£75,114−0.38Dominated

ICER, incremental cost-effectiveness ratio; QALYs, quality-adjusted life years

(a)

28 days aztreonam lysine (nebulised) alternating with 28 days tobramycin (nebulised))

From: Appendix K, Health Economics

Cover of Cystic Fibrosis
Cystic Fibrosis: Diagnosis and management.
NICE Guideline, No. 78.
National Guideline Alliance (UK).
Copyright © NICE 2017.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.